Skip to main content

Advertisement

Figure 2 | BMC Cancer

Figure 2

From: Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer

Figure 2

Kaplan-Meier survival analysis for NSCLC patients. The P-value was determined using the log-rank test. (A) Comparison of the overall survival (OS) between NOK negative and NOK positive NSCLC patients. (B) Comparison of the OS between pTNM I/II and pTNM III/IV patients. (C) Comparison of the OS between NOK negative and NOK positive SCC patients. (D) Comparison of the OS between NOK negative and NOK positive ADC patients. (E) Comparison of the OS between NOK negative and NOK positive pTNM I/II patients. (F) Comparison of the OS between NOK negative and NOK positive pTNM III/IV patients.

Back to article page